Vt., renewed his criticism of drugmaker Novo Nordisk on Tuesday, claiming that the CEOs of major generic pharmaceutical companies have told him that they can produce and sell its blockbuster diabetes drug Ozempic for less than $100 a month.

Ozempic is a popular diabetes drug that is also used for weight loss by suppressing appetite. Sanders expressed confidence that Novo Nordisk could be persuaded to lower U.S. prices for its weight-loss drugs, Ozempic and Wegovy, by exposing price disparities.

(Reuters) - U.S. Senator Bernie Sanders said on Tuesday he received confirmation from major generic pharmaceutical companies that they could sell copycat versions of Novo Nordisk's diabetes drug Ozempic for less than $100 a month.

Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell generic versions of the drugs for

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine Ozempic at $100 per month. Read more here.

Senator Bernie Sanders says generic drugmakers could sell Ozempic for less than $100 a month instead of nearly $1000.